Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets-Reference-Cited by-同舟云学术

Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets

Published:2023-02 Issue: Volume:208 Page:115405
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Todisco Simona,Musio Biagia,Pesce Vito,Cavalluzzi Maria Maddalena,Petrosillo Giuseppe,La Piana Gianluigi,Sgobba Maria Noemi,Schlosserová Nikola,Cafferati Beltrame Lucas,Di Lorenzo Rosa,Tragni Vincenzo,Marzulli Domenico,Guerra Lorenzo,De Grassi Anna,Gallo Vito,Volpicella Mariateresa,Palese Luigi Leonardo,Lentini Giovanni,Pierri Ciro Leonardo

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference473 articles.

1. Enhancing Mitochondrial Health to Treat Hypertension;Eirin;Curr. Hypertens. Rep.,2018

2. Protective role of the mitochondrial fusion protein OPA1 in hypertension;Robert;FASEB J.,2021

3. Role of mitochondrial oxidative stress in hypertension;Dikalov;Am. J. Physiol. - Hear. Circ. Physiol.,2013

4. Mitochondrial injury and dysfunction in hypertension-induced cardiac damage;Eirin;Eur. Heart J.,2014

5. Mitochondrial pharmaceutics;Weissig;Mitochondrion.,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and In Vivo Evaluation of Isosteviol Derivatives as New SIRT3 Activators with Highly Potent Cardioprotective Effects;Journal of Medicinal Chemistry;2024-04-04

2. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin;Frontiers in Cardiovascular Medicine;2024-03-08

3. Molecular cardiopharmacology and Therapeutics-I;Biochemical and Molecular Pharmacology in Drug Discovery;2024

4. Landscape of molecular crosstalk between SARS-CoV-2 infection and cardiovascular diseases: emphasis on mitochondrial dysfunction and immune-inflammation;Journal of Translational Medicine;2023-12-16

5. Mitochondrial iron regulation as an emerging target in ischemia/reperfusion injury during kidney transplantation;Biochemical Pharmacology;2023-09